BEAM
Beam Therapeutics Inc Earnings
$23.45
Earnings Summary
Revenue | $8.47Mn |
Net Profits | $-102.29Mn |
Net Profit Margins | -1208.26% |
Beam Therapeutics Inc’s revenue fell -28.08% since last year same period to $8.47Mn in the Q2 2025. On a quarterly growth basis, Beam Therapeutics Inc has generated 13.33% jump in its revenue since last 3-months.
Beam Therapeutics Inc’s net profit fell -12.34% since last year same period to $-102.29Mn in the Q2 2025. On a quarterly growth basis, Beam Therapeutics Inc has generated 6.39% jump in its net profits since last 3-months.
Beam Therapeutics Inc’s net profit margin fell -56.22% since last year same period to -1208.26% in the Q2 2025. On a quarterly growth basis, Beam Therapeutics Inc has generated 17.4% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -1.03 |
EPS Estimate Current Year | -1.03 |
Beam Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -1.03 - a 7.21% jump from last quarter’s estimates.
Beam Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -1.03.
Key Ratios
Earning Per Share (EPS) | 0 |
Beam Therapeutics Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q3 2025. This indicates that the Beam Therapeutics Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-11-10 | -1.03 | 0 | 100% |
2025-08-05 | -1.11 | -1 | 9.91% |
2025-05-06 | -1.17 | -1.24 | -6.04% |
